Pet-yksikkö

Julkaisut 2005
Publications 2005

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aalto S et al. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand (11C)FLB 457.
2 Aalto S et al. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.
3 Aalto S et al. Regression analysis utilizing subjective evaluation of emotional experience in PET studies on emotions.
4 Bax JJ et al. Cardiac resynchronization therapy. Part 1- Issues before device implantation.
5 Bax JJ et al. Cardiac resynchronization therapy. Part 2 - Issues during and after device implantation and unresolved questions.
6 Brück A. Cognitive Impairment in Early Parkinson's Disease. A Positron Emission Tomography and Magnetic Resonance Imaging Study.
7 Brück A et al. Cortical 6-(18F)fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.
8 Grönholm P et al. Naming of newly learned objects: A PET activation study.
9 Hannukainen J et al. In vivo measurements of glucose uptake in human Achilles tendon during different exercise intensities.
10 Hannukainen JC et al. Cardiac structure and function in monozygotic twin pairs discordant for physical fitness.
11 Hesse B et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.
12 Hietala J. Vakavat mielenterveyden häiriöt tutkimuksellisena ja hoidollisena haasteena.
13 Hietala J et al. Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain.
14 Hirvonen J. Brain Dopamine Receptors and Genetic Risk For Schizophrenia. A Twin Study Using Positron Emission Tomography.
15 Hirvonen J et al. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.
16 Ingman K et al. Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing.
17 Islam Md.S et al. Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms and their association with carotid artery intima-media thickness in the Finnish population. The Cardiovascular Risk in Young Finns Study.
18 Järvenpää T et al. Binge drinking in midlife and dementia risk.
19 Kaasinen V et al. Mapping brain structure and personality in late adulthood.
20 Kalliokoski KK et al. Relationship between muscle blood flow and oxygen uptake during exercise in endurance-trained and untrained men.
21 Kalliokoski KK et al. The effect of dynamic knee-extension exersise on patellar tendon and quadriceps femoris muscle glucose uptake in humans studied by positron emission tomography.
22 Kalliokoski RJ et al. Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease.
23 Kalliokoski T et al. An autoradiographic study of (18F]FDG uptake to islets of Langerhans in NOD mouse.
24 Karlsson HKR et al. Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study.
25 Karrasch M et al. CERAD test performance in amnestic mild cognitive impairment and Alzheimer's disease.
26 Kauppinen-Mäkelin R et al. A nationwide survey of mortality in agromegaly.
27 Kemppainen J et al. High intensity exercise decreases global brain glucose uptake in humans.
28 Knuuti J, Sipola P. Is it time for cardiac innervation imaging?
29 Knuuti J et al. Sydämen non-invasiivinen kuvantaminen sepelvalmitotaudin diagnostiikassa Suomessa.
30 Koivula T et al. Simplified synthesis of N-(3-(18F)fluoropropyl)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)nortropane ((18F)beta-CFT-FP) using (18F)fluoropropyl tosylate as the labelling reagent.
31 Koort JK et al. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to staphylococcus aureus.
32 Koponen H et al. Psykoosilääkehoitoon liittyvien metabolisten muutosten seuranta .
33 Kotilainen P et al. Riedel's thyroiditis in a patient with multiple sclerosis.
34 Laakso A et al. The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects.
35 Laaksonen M. The Acute Effects of Exercise on Skeletal Muscle Blood Flow. Positron Emission Tomography Studies in Healthy Subjects.
36 Lahti J et al. Novelty seeking: interaction between parental alcohol use and dopamine D4 receptor gene exon III polymorphism over 17 years.
37 Laitio T et al. Prediction of postoperative myocardial ischemia by fractal heart rate dynamics (in response).
38 Lautamäki R et al. Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study.
39 Lendvai G et al. Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.
40 Lund VE et al. Effect of age and repeated hyberbaric oxygen treatments on vagal tone.
41 Långsjö J W et al. S-ketamine anesthesia increases cerebral blood flow in excess of the metabolic needs in humans.
42 Långsjö J. The Effects of Ketamine on Cerebral Blood Flow and Metabolism.
43 Maksimow A et al. Correlation of EEG spectral entropy with regional cerebral blood flow during sevoflurane and propofol anaesthesia.
44 Martikainen IK et al. Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia.
45 Minn H, Knuuti J. Kliininen PET-kuvantaminen tänään.
46 Minn H et al. In response to Wang et al.
47 Minn H. PET and SPECT in low-grade glioma.
48 Mäkinen J et al. Increased carotid atherosclerosis in andropausal middle-aged men.
49 Mäkinen T. Osteomyelitis and Orthopedic Implant Infections. 18F-FDG and 68Ga-chloride PET Imaging, Local Antibiotic Therapy and Antibiotic-releasing Bioresorbable Implants.
50 Mäkinen TJ et al. Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus.
51 Mäkinen TJ et al. Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to staphylococcus aureus.
52 Naum A et al. Motion detection and correction for dynamic 15O-water myocardial perfusion PET studies.
53 Nyman M et al., ed. Abstracts of the X Turku PET Symposium, May 28-31, 2005. Turku, Finland.
54 Pawitan Y et al. Non-Gaussian smoothing of low-count transmission scans for PET whole-body studies.
55 Penttilä J, Hietala J. Proposed mechanisms of action of SSRIs.
56 Penttilä J et al. Analysis of rapid heart rate variability in the assessment of anticholinergic drug effects in humans.
57 Penttilä J et al. Subanaesthetic doses of ketamine impair cardiac parasympathetic regulation.
58 Penttilä J et al. Measurement of anticholinergic effects of psychotropic drugs in humans.
59 Penttilä J et al. Antikolinergisen lääkevaikutuksen merkitys ja mittaaminen.
60 Pälvimäki EP et al. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
61 Raitakari OT et al. Endothelial function in healthy 11-year-old children after dietary intervention with onset in infancy. The special Turku coronary risk factor intervention project for children (STRIP).
62 Salmi E et al. Subanesthetic ketamine does not affect 11C-flumazenil binding in humans.
63 Soilu-Hänninen M et al. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.
64 Sundell J et al. Lifetime glycaemic exposure predicts reduced coronary vasoreactivity in type 1 diabetic subjects.
65 Sundell J. Obesity and diabetes as risk factors for coronary artery disease: from the epidemiological aspects to the initial vascular mechanisms.
66 Sundell J et al. Increased lipoprotein(a) is associated with reduced myocardial vasoreactivity in young healthy men.
67 Sundell J et al. Hyperkalemian aiheuttama bradykardia.
68 Venojärvi M et al. Role of skeletal muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a long-term exercise and dietary intervention.
69 Vikman S et al. Sepelvaltimotautikohtauksen hoito Suomessa.
70 Viljanen APM et al. Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: A double-blind, randomized study with metformin.
71 Virtanen KA et al. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes. A positron-emitting tomography study.
72 Volanen I et al. Serum lipid profiles poorly correlate with chlamydia pneumoniae, helicobacter pylori, and cytomegalovirus seropositivity in prospectively followed-up healthy children.
73 Vänttinen M et al. Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake.
74 Vänttinen M et al. The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma 2 gene on skeletal muscle glucose uptake depends on obesity - a positron emission tomography study.
Julkaisutietokanta 4.10.2006 Publications Data Base 4.10.2006